Skip to Content

Allied Corp - Stock Quote ALID

Rating as of

Morningstar's Allied Corp Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Allied Corp's Company Profile

Business Description

Allied Corp is an international cannabis company with a mission to help people suffering from Post-Traumatic Stress Disorder (PTSD) by researching, creating, and producing targeted cannabinoid health solutions. The company uses an evidence-informed scientific approach to make this mission possible through cutting-edge pharmaceutical research and development, plant-based production, and the development of therapeutic products. The company operates in two segments which include Allied and Allied Colombia. Its geographical segments consist of Colombia and Canada.

Contact
1405 St. Paul Street, Suite 201
Kelowna, BC, V1Y 9N2, Canada
T +1 877 255-4337
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Feb 28, 2022
Fiscal Year End Aug 31, 2022
Stock Type Distressed
Employees 15